Skip to main content
. 2021 Nov 27;13(11):1707–1726. doi: 10.4254/wjh.v13.i11.1707

Table 6.

Pharmacotherapy used for mitochondrial diseases

Drug
Pediatric dose
Remark
Coenzyme Q: (1) Ubiquinol form; (2) Ubiquinone form 2-8 mg/kg/d in BD dosing; 10-30 mg/kg/d BD dosing Preferably had after meals; Most effective and most used therapy; Free radical scavenger; Bypasses complex I
Idebenone 5 mg/kg/d Synthetic form of CoQ; Penetrates blood-brain barrier
L-carnitine 10-100 mg/kg/d IV or oral divided 3 times/d Avoid in long chain FAO-Ds: May lead to cardiac arrhythmias
Creatine 0.1 g/kg PO, OD Used for repletion of muscle phosphocreatine levels
L-arginine 500 mg/kg IV per day for 1-3 d followed by 150-300 mg/kg oral daily in BD dosing Used for acute stroke; Watch for hypotension while infusion; Evidence is anecdotal
Thiamine 100 mg/d Cofactor of PDH; useful for thiamine responsive PDH deficiency; Helpful in leigh disease
Riboflavin 50-400 mg/d Give at night time before sleep; Shown to be useful in ACAD9 mutations; Flavin precursor for complex I & II
Vitamin C 5 mg/kg/d OD Antioxidant; Artificial electron acceptor
Vitamin E Variable dosing, up to 25 IU/kg/d OD (avoid > 400 IU/d) Absorption better when taken with meals
Dichloroacetate 25-50 mg/kg/d Improves lactic acidosis

BD: Twice daily; CoQ: Coenzyme Q; FAO-D: Fatty acid oxidation defects; IV: Intravenous; PDH: Pyruvate dehydrogenase; PO: Per oral; OD: Once daily.